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and 3Department of Environmental and Occupational Health, University of Pittsburgh, Pittsburgh, PennsylvaniaABSTRACT Cardiolipins (CL) represent unique phospholipids of bacteria and eukaryotic mitochondria with four acyl chains
and two phosphate groups that have been implicated in numerous functions from energy metabolism to apoptosis. Many pro-
teins are known to interact with CL, and several cocrystal structures of protein-CL complexes exist. In this work, we describe the
collection of the first systematic and, to the best of our knowledge, the comprehensive gold standard data set of all known CL-
binding proteins. There are 62 proteins in this data set, 21 of which have nonredundant crystal structures with bound CL
molecules available. Using binding patch analysis of amino acid frequencies, secondary structures and loop supersecondary
structures considering phosphate and acyl chain binding regions together and separately, we gained a detailed understanding
of the general structural and dynamic features involved in CL binding to proteins. Exhaustive docking of CL to all known struc-
tures of proteins experimentally shown to interact with CL demonstrated the validity of the docking approach, and provides a rich
source of information for experimentalists who may wish to validate predictions.INTRODUCTIONCardiolipin (CL) is an unusual anionic phospholipid with
two negatively charged phosphate groups in its polar head
and four hydrophobic acyl chains (1,2). CL is the signature
phospholipid of the inner bacterial membrane and the inner
mitochondrial membranes of eukaryotic cells where its
presence is important for the proper structural arrangements
and functioning of a number of proteins (3,4). In addition to
its structural role for the proteins of the electron transport
chain, it also plays roles in different stages of apoptosis
(5), adenylate translocase ion transport (6), and transloca-
tion by NDPK-D (7). Lately, extramitochondrial functions
of CL in regulating the process of mitophagy (8–11) and
orchestrating the NLRP3 inflammasome and maturation of
IL-1b (12,13) have been documented. Not surprisingly,
CL has been implicated in a number of different diseases,
such as Barth syndrome, diabetes, heart disease, radiation
damage, Parkinson’s disease, and others. Some of these
roles are membrane related, i.e., aberrant CL concentrations
and distributions were shown to affect the structure, dy-
namics, and permeability of the mitochondrial membranes
and CL is known to appear on the surface of the cell and
also on the plasma membrane during apoptosis. On the other
hand, interactions with proteins are crucial for understand-
ing CL’s functions and dysfunctions. Numerous proteins
have been reported to interact with CL (reviewed inSubmitted March 19, 2015, and accepted for publication July 13, 2015.
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0006-3495/15/09/1282/13(14,15)), and in cases where cocrystal structures are known,
individual CL binding patches (BPs) have been identified.
However, when there is no structure, the location and
mode of binding can be difficult to establish. For example,
for cytochrome c at least three distinct BPs have been pro-
posed (16–21). Here, we aimed to retrieve a comprehensive
list of all known CL-protein pairs to date. The properties of
the BPs were investigated in detail using molecular
modeling approaches for the available cocrystal structures.
Molecular modeling has been used extensively to predict
interactions between small molecules and proteins, essential
for example in the drug discovery process (22). Identifying
and studying the BPs of specific ligands to a group of pro-
teins helps understanding of the molecular mechanisms gov-
erning such interactions (23). In turn, this knowledge may
help in the design of proteins with specific functions
(24,25), and in development of inhibitors and drugs target-
ing the identified binding region (26). A wide variety of ap-
proaches have been developed and employed to address the
BP identification problem in silico (recently reviewed in
(27)). Most detailedmethods, such as the 3DQSAR relation-
ship, require abundant previous structural knowledge on the
binding regions of the ligand to its target. These methods
have been successfully used, e.g., for G-protein coupled re-
ceptors (28). However, when computational resources and
structural information are limited, patch analysis of the bio-
physical properties of the binding sites become particularly
informative (29). Here, we analyzed the trends of amino
acid distribution and secondary structure usage in CL-BPs,
to differentiate between the regions that bind the polar head-
group and the acyl chains of the CL molecules, respectively.http://dx.doi.org/10.1016/j.bpj.2015.07.034
Cardiolipin Interactions with Proteins 1283Additionally, taking advantage of the recently discovered
overrepresentation of certain supersecondary structural
motifs in protein-protein interaction interfaces (30), we
searched for such motifs in CL-BPs. Finally, where experi-
mental structural data was not available for analysis, compu-
tational predictions by docking methods were performed to
provide valuable insight into the binding modes of the ligand
to its target (31,32). We therefore also conducted a compre-
hensive analysis of the potential validity of such predictions
in the case of CL-binding proteins.MATERIALS AND METHODS
Preparing a database of known CL-binding
proteins
A list of proteins experimentally demonstrated to interact with CL (the gold
standard), was compiled using four different strategies: 1) extensive litera-
ture search, 2) retrieval from the UniProtKB database (33), 3) retrieval from
the Protein Data Bank (PDB) (34), and 4) search for the term cardiolipin
binding in the Gene Ontology browser—Quick GO (35), as follows. In
addition, where available, the PDB entry was obtained from the Cross-
reference section of the protein description in the UniProtKB database.
Extensive literature search
Starting with previous reviews of CL-binding proteins (14,15) we extended
the search to publications in Pubmed using cardiolipin binding as the search
term. Different attributes of the CL-binding proteins detailed in the identi-
fied publications (such as their name, gene name, organism name, EC num-
ber, PDB entries) were then used to search UniProtKB. The UniProt entry
with the best match of the protein attributes was included in the gold
standard.
Retrieval from the UniProtKB database
The keyword cardiolipin was used to search the UniProtKB database, re-
sulting in further identification of proteins that interact with CL. Such inter-
actions were later verified by literature review.
Retrieval from the PDB
Additional CL-protein interactions were identified by searching for struc-
tures containing CL in the PDB files (34). The chain IDs in the remarks
were used to retrieve the UniProt entry of the protein.
Gene ontology cardiolipin binding term search
The GO:1901612 ID, which corresponds to the gene ontology term cardio-
lipin binding, was used to search the Quick GO browser. The search results
revealed additional CL-binding proteins, which were recorded along with
the UniProtKB references provided in the Quick GO search results. Liter-
ature search was used to verify the interactions of these proteins with CL.Predicting 3D structures of proteins in the gold
standard without known structures
For proteins without annotated PDB entries, 3D models were obtained us-
ing the online protein structure homology-modeling server—SWISS-
MODEL (36,37). Models having QMEAN Z-scores >2.0 were selected
and included for obtaining structure-based features of the protein. For
models having a QMEAN4 score <2.0 and Torsion Z-score >2.0,
the Optimize plugin (38) for the PyMol software (10,39), was used to
optimize the models. The optimized models were then uploaded to theQMEAN server (40,41) for reevaluation. The models with a QMEAN
Z-score >2.0 were included for obtaining structure-based features of
the protein.Homology assessment
To avoid overrepresentation of close homologs in the analysis of BPs thus
ensuring no redundant information about CL-binders is included in the gold
standard, we removed proteins sharing >90% sequence identity using the
CD-HIT Suite (42).Definition of BPs
CL-BPs were defined as the set of amino acids in the interacting protein
chain containing at least one atom within a distance of 5 A˚ to any CL
atom, for each protein chain/CL molecule pair. This definition was nar-
rowed further to define three subsets of BPs to consider the specific nature
of negative electric charges in the CL polar head and hydrophobic interac-
tions involving the acyl chains. We thus defined phosphate binding patches
(PBPs) as the set of amino acids in the interacting protein chain containing
at least one atom within a range distance of 5 A˚ to any phosphorous atom in
the CL molecule. Analogously, we defined hydroxyl binding patches
(OBPs) as the set of amino acids in the interacting protein chain containing
at least one atom within a range distance of 5 A˚ to the oxygen atom in the
central glycerol moiety in CLmolecule. Hence, a PBP or a OBP will always
be a subset of the corresponding general BP given by the first definition in
this subsection. Acyl binding patches (ABPs) were defined as the asym-
metric difference set operation between the BP and the union of PBP and
OBP for each CL-protein chain pair (i.e., an ABP is defined by the subset
of residues in the BP neither belonging to the corresponding PBP nor to the
corresponding OBP). All these definitions were applied to each crystallo-
graphic structure obtained from the PDB that contained 3D coordinates
for both the CL molecule and its binding protein.Sequence- and structure-based features
For proteins with known 3D structure, their amino acid composition (pri-
mary structure) was obtained directly from the corresponding PDB file.
The assignment of secondary structure in those proteins, and the solvent
accessibility was obtained by using DSSP 2.0.4 (43). We categorized the
different annotations of DSSP as follows: H, G, and I as Helix; E and B
as strand; any other annotation as Coiled coil. Whenever DSSP was unable
to produce an assignment for a particular amino acid, this amino acid was
excluded from the secondary structure analysis. Finally, the assignment of
supersecondary structures or loops on such proteins was obtained from
Markov Clustering classification terms listed in the ArchDB database
(44). Relative accumulated frequencies and propensities of amino acids
and secondary structures, and relative accumulated frequencies of loops
were computed and represented using R (45) (see Metrics section below).
Such computation was applied to five different data sets: 1) the complete
protein chain, 2) BPs, 3) PBPs, 4) OBPs, and 5) ABPs. For this purpose,
a loop was considered to be included in the relevant protein region for a
given analysis scope if at least one amino acid of the loop belonged to
such a region.Metrics
The relative frequency of an element in a population is given by
FðiÞ ¼ NðiÞ=T; (1)
where N(i) represents the total number of observations of such element and
T the total number of elements in the population. In this work, we refer toBiophysical Journal 109(6) 1282–1294
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number of observed instances of such amino acid in a given region (i.e.,
whole chain or any type of binding patch) over the total number of amino
acids (any one) in the same region. For secondary structures, we consider
the total number of residues within a certain structural type in a given region
over the total number of residues in such structural type on the same region.
For loops, the relative accumulated frequency would be the number of in-
stances of a particular loop type in a certain region over the total number
of loops in that region.
Propensity of a certain amino acid or secondary structure element is







where N(i)surf is the total count of exposed instances of such amino acid
or of residues in such secondary structure element, and Tsurf is the totalnumber of exposed amino acids. We considered a residue exposed if
its relative solvent accessibility (46) was higher than 25% (47). Within
a defined set of protein crystals, every amino acid or secondary struc-
tural element will have a characteristic N(i)surf/Tsurf ratio, K(i). Compared
to frequencies, the computation of propensities takes into account the
natural inclination of a certain element (amino acid or secondary struc-
tural element) to be exposed in the protein surface. Hence, propensities
will highlight, among the studied population, elements which are
abundant in relation to the natural tendency of such element to be
exposed. To study BPs, this measure can pinpoint key elements for the
interaction (48).
Statistical significance of differences between the different measures
analyzed was assessed using the Chi-squared test as implemented in R
(45). The null model considered the compared elements have equal F(i)
(see Eq. 1) and equal K(i) (see Eq. 2). P-values from these Chi-squared tests
are given throughout this work. For a given comparison, a p-value <¼ 0.05
denotes statistically significant differences, whereas a p-value >0.05
denotes that the differences observed between the two analyzed ele-
ments could also be observed by chance. To stress this breakpoint, we
illustrate p-values in a double colored scale, linear values from dark
red (1) to light pink (0.05) to denote nonsignificant p-values and a logarith-
mic scale ranging from light blue (0.05) to dark blue (0) for significant
p-values.Docking
Proteins were classified into two groups for structural analysis, 1) CL coc-
rystal structures, i.e., proteins having a PDB entry with a CL structure pre-
sent in the PDB file; 2) proteins having a PDB entry, but no CL structures
included; 3) proteins only having a Swiss model entry. Docking was essen-
tial for proteins belonging to the second and third category, but it was also
performed for the proteins in the first category to test the compatibility of
the docking results with the CL-binding sites given in the PDB files.
AutoDock Tools (49) was used to obtain PDBQT files of the receptors
(proteins) and ligand (CL), and for determining the dimensions of the
grid box for each protein chain, which acts as the search space for docking
the ligand. The polar hydrogens were added to the protein chain molecule
followed by computing Gasteiger charges for the molecule. The result was
used to compute the corresponding PDBQT file. The CL species selected as
ligand in all cases irrespective of the CL species bound in the cocrystal
structures was 1,10,2,20-tetralinoleoyl-CL (TLCL), as it is an oxidizable
species of CL and the most abundant CL species found in mammalian
mitochondria (50). AutoDock Vina (51) was employed to run molecular
docking simulations. Default parameters were used and the docking specific
parameters are provided in File S5. Results were analyzed using PyMol (39)
and all pymol sessions are provided in Files S3 and S5 for single chain and
multiple chain dockings, respectively. The top nine different docking posesBiophysical Journal 109(6) 1282–1294of CL were manually classified into binding sites, i.e., those modes of the
docked CL that bound the receptor at the same location were grouped
into a common binding site. For proteins having CL costructures in
the PDB file, overlap of each predicted binding site with each crystallo-
graphic CL site was recorded. An overlap was identified whenever the phos-
phate heads of the docked CL were in proximity to those of the CL
costructure and both the molecules shared similar orientations of the acyl
chains. Proteins with no overlapping predicted site to the crystallographic
one were redocked and this time the top 50 different docking poses were
considered for manual classification into binding sites and posterior
analysis.
Protein chains were docked individually, i.e., if other chains were present
in the pdb file, they were removed for docking. Therefore, in a few isolated
cases, we found some of the CL docking poses to be partially overlapping
with these other chains. These instances were recorded as clashes. We also
retrieved the amino acid residues of each receptor protein at 5 A˚ distance
from each CL docking pose.RESULTS
Identification of CL-binding proteins
We identified a total of 62 CL-binding proteins by dif-
ferent procedures described in the Materials and Methods
section, and these proteins are listed in Table 1. Detailed
information about these gold standard proteins is pro-
vided in Table S1. 26 of them were identified from
extensive literature search, 12 were retrieved from the
UniprotKB database, 22 were obtained from the PDB,
and 2 from GO term search. Crystallographic data contain-
ing CL molecules and their protein binding partners were
available for 22 of these proteins, represented in 34
different PDB protein chains. For another 21, crystallo-
graphic data was available but not in the presence of the
CL binding molecule (30 PDB protein chains). 3D struc-
ture was assigned to six proteins using homology
modeling. We were not able to assign 3D structure to the
13 remaining proteins. To avoid overrepresentation of
near identical structures, we pruned our analysis set of pro-
teins sharing >90% sequence identity with others using
CD-hit (42). See Table S1 for details on which protein
chains were removed. This procedure resulted in a set con-
taining 21 proteins with CL cocrystals observed in 15
different PDB records.Identification and analysis of CL-BPs
As some of the protein chains had more than one CL mole-
cule bound, a total of 27 CL-BPs were identified in 21
protein cocrystal structures with CL. Within BPs, we differ-
entiated between regions with preference for binding of the
polar headgroup (PBPs and OBPs) of CL molecule and re-
gions with preference for binding the acyl chains of CL
(ABPs) (see Materials and Methods section). 15 of the 21
proteins were also mapped to supersecondary structures in
the ArchDB database, referred hereinafter as loops (44).
Loops were mapped to 14 BPs, 12 ABPs, 5 OBPs, and
9 PBPs.
TABLE 1 Proteins in gold standard
Protein Name Mb CL PDB_Chain Ref.
Alpha-MGlcDAG synthase Y NA 1Z2T_A (52)
Phospholipase A2 N NA 1POC_A (53)
Cyt. c oxidase sub. 1 Y NA 2OCC_A (54)
Cyt. c oxidase sub. 7A1, mit. Y NA 2OCC_J (54)
Cyt. c oxidase sub. 7C, mit. Y NA 2OCC_L (54)
ADP/ATP translocase 1 Y CDL 1OKC_A (55)
Cyt. b-c1 complex sub. 1, mit. Y CDL 1SQP_A (56)
Cyt. c1, heme protein, mit. Y CDL 1SQP_D, (56),
2A06_D, Q (57)
Cytochrome b Y CDL 2A06_C, P (57)
Adrenodoxin, mit. Y NA 2BT6_A, B (58,59)
ATP synthase sub. beta, mit. Y NA 2CK3_
D, E, F
(60)
Cyt. b-c1 complex subunit 8 Y CDL 2YBB_G, (61),
1SQP_G (56)
Cholesterol desmolase Y NA 3MZS_
A,B,C,D
(58,62)
Protein S100-B N NA 3RM1_A (63)
Cyt. c oxidase sub. 6A2, mit. Y CDL 3WG7_G, T (64)
Cyt. c oxidase sub. 3 Y CDL 3WG7_C, P (64)
FDH-N sub. gamma Y CDL 1KQF_C (65)
FDH-N sub. beta Y CDL 1KQG_B (65)
Cyt. c Y NA 3O1Y_
A, B, C
(66)
Chr. replication initiator prot.
DnaA
Y NA 1J1V_A (67)
Cyt. b-556 Y CDN 2ACZ_C (68)
DNA topoisomerase 1 N NA 1MW9_X (69)
Cyt. b Y CDL 3TGU_C, P (70)
Mit. ubiquinol-cyt. c reductase
ubiquinone-binding prot. qp-c
Y CDL 3TGU_G (70)
Mit. cyt. c1, heme protein Y CDL 3TGU_Q (70)
Prohibitin Y NA 1LU7_A (71)
Beta-2-glycoprotein 1 N NA 3OP8_A, B (72,73)
ABC transporter 10 prot. Y CDL 3ZDQ_A (74)
Acyl-CoA thioesterase THEM5 Y NA 4AE7_A (75)
Caspase-8 Y NA 4JJ7_A (76)
Apoptosis regulator BAX Y NA 4BD2_A (77)
Uncharacterized protein Y CDL 4A2N_B (78)
BH3-interacting domain death
agonist
Y NA 2VOI_B (79,80)
Antigen-presenting glycoprot.
CD1d1
Y CD4 3MA7_A, C (81)
Neutral ceramidase N NA 2zws_A (82)
Carnitine/acylcarnitine translocase Y NA 2BMN_A (83)
Reaction center prot. M chain Y CDL 4LWY_M (84)
Reaction center prot. M chain Y CDL 4N7L_M (85)
ADP,ATP carrier prot. 2 Y CDL 4C9G_A (86)
ADP,ATP carrier prot. 3 Y CDL 4C9J_A, B (86)
Cyt. b Y CDL, 1KB9_C, (87),
CN3, 3CX5_N, (88),
CN5 3CX5_C (88)
Cyt. c1, heme prot. mit. Y CDL, 1P84_D, (89),
CN3 3CX5_D (88)
Sapecin N NA 1L4V_A (90)
Malate dehydrogenase, mit. Y NA model (59)
Thiosulfate sulfurtransferase Y NA model (91)
Tafazzin Y NA model (76)
Serine/threonine-prot. kinase N1 Y NA model (92)
Creatine kinase S-type, mit. Y NA model (93)
Mit. glycerol-3-phosphate
dehydrogenase
Y NA model (94)
(Continued on next page)
Table 1. Continued
Protein Name Mb CL PDB_Chain Ref.
NADH dehydrogenase sub. 1 Y NA NA (95)
Phosphate carrier prot mit. Y NA NA (96)
Prot. UPS1, mit. Y NA NA (97)
Prot. UPS2, mit. Y NA NA (97)
Lysocardiolipin acyltransferase 1 Y NA NA (98)
Phospholipid scramblase 3 Y NA NA (99,100)
Stomatin-like prot. 2, mit. Y NA NA (101)
MICOS complex subunit MIC27 Y NA NA (102)
Phospholipid-transporting
ATPase IC
Y NA NA (103)
Glycerol-3-phosphate acyltransf.
1, mit.
Y NA NA (104)
Carbamoyl-phosphate sinthase I Y NA NA (105)
Neoverrucotoxin subunit alpha N NA NA (106)
AMP deaminase 1 isoform M N NA NA (107)
The column Protein name shows the UniProtKB recommended name of the
protein. Some records use alternate and short names as provided in
UniProtKB for convenience. Recurring words are abbreviated: mit. for
mitochondrial, cyt. for cytochrome, sub. for subunit, chr. for chromosomal,
prot. for protein, and transf. for transferase. The column Mb indicates if
protein is a membrane or nonmembrane protein (Y and N, respectively).
CL shows the structure ID(s) of the cardiolipin costructure(s) given in
the PDB file of the protein. PDB_chain indicates the chain of the pro-
tein’s PDB structure known to interact with cardiolipin. Records of
proteins included in the nonredundant cocrystals subset are shown in
bold face. Note that the reaction center protein M chain in PDB 4NL7
was excluded from this subset because it is 100% identical to reaction cen-
ter proteinM chain in PDB 4LWY, although both proteins are from different
organisms.
Cardiolipin Interactions with Proteins 1285We have used the set of CL-binding protein cocrystal
structures to analyze the characteristics of CL-BPs in
proteins in terms of their amino acid composition (Figs. 1
and S1), secondary structure (Figs. 2 and S2), and superse-
condary structure/loops (Fig. 3). Finally, we compared the
values of these three features in the CL-BPs, ABPs, OBPs,
and PBPs to the values obtained from the complete CL-in-
teracting proteins.
Electrostatic-driven amino acid bias trends in CL-binding
regions
The amino acid composition shown in Fig. 1 indicates that
there is an overrepresentation of positively charged residues
in PBPs and OBPs, primarily Arg and Lys residues but
also His, when compared to ABPs. This suggests an impor-
tant role of electrostatic interactions in attracting CL
molecules to their protein binders, as has been proposed
for specific proteins previously (108–110). The fact that
negatively charged residues (Asp and Glu) are underrepre-
sented in BPs further supports this hypothesis. Strikingly,
although Asp is only underrepresented in PBPs, demon-
strating its incompatibility to interact with the negative polar
head of CL, Glu is completely disallowed in the whole CL-
binding region (Figs. 1 and S1), suggesting there exist
further restrictions for the usage of this amino acid in
CL-BPs.Biophysical Journal 109(6) 1282–1294
FIGURE 1 Propensities of observed amino acids in all protein chains analyzed (blue), BPs (green), ABPs (dark yellow), OBPs (purple), and PBPs (red).
The p-values for the statistical significance of differences between propensities of each amino acid in different BPs are shown in the lower panel. NA (gray)
indicates that two empty sets were compared and hence no statistics can be computed. In red and using a linear scale, nonsignificant p-values ranging from 1
(darker red, indicates that greater differences could always be observed in a random set) to 0.05 (lighter red) are shown. In blue and using a logarithmic scale,
significant p-values are shown, from 0.05 (light blue, differences observed could be reproduced by random only in 5 over 100 cases) to p-values near 0 (dark
blue, the probability to observe such differences by chance is the lowest).
1286 Planas-Iglesias et al.Hydrophobic interactions with the acyl chains
As expected, hydrophobic amino acids dominate the ABPs
(Figs. 1 and S1). In particular, Leu, Ile, and Val are most
frequent. The accumulated frequencies of Leu, Ile, and
Val alone represent 24% of the amino acid content of the
studied proteins, and sum up to 15% in the PBPs. In com-
parison, these hydrophobic amino acids are overrepre-
sented in BPs and ABPs, representing 31% and 40% of
their amino acid content, respectively. Although these three
amino acids are the most strikingly overrepresented ones,
Phe, Thr, Met, and Trp are also more frequent in BPs
when compared to all chains. Grouping amino acids by hy-
drophobicity alone is of course a simplification, and this is
most clearly visible when looking at Tyr. Although a hy-
drophobic amino acid, it is rarely found in ABPs, either
due to the hydrophilic OH group or its role in regulation,
i.e., the potential to be phosphorylated, which would pre-
vent CL binding. Significance values of frequencies and
propensities comparisons between different amino acids
are provided in File S1.Flexibility trends in CL-binding regions
A remarkable bias was observed in the distribution of amino
acids related to protein flexibility (Fig. 1): Gly, which im-
parts flexibility is highly overrepresented and Pro, which
generally introduces rigidities in the 3D structure of proteins
is highly underrepresented in PBSs. This observation sug-
gests a requirement for higher flexibility in the region bind-
ing the polar headgroups of CL. The opposite is observed for
the ABPs. Here, Gly is underrepresented, although Pro is
also but less strongly underrepresented when compared to
all chains. This indicates that structured regions favor the
binding of the acyl chains.Biophysical Journal 109(6) 1282–1294Secondary structure analysis
The analysis of secondary structure compositions is shown
in Figs. 2 and S2. Overall, helices are most frequent, but
this is expected as the majority of known CL-binding pro-
teins with structures are integral membrane proteins of the
helical bundle type (Table 1). We therefore concentrated
on the differences in the preference for secondary structures
in BPs, PBPs, and ABPs as compared to the full chains.
Although ABPs are mainly composed of helical secondary
structures and only contain ~10% unorganized regions,
the percentage of residues with coiled-coil conformation
remarkably rises to almost 40% in PBPs. Although this
value is similar to that of the whole amino acid chain, the
important fact is its increased percentage of coiled-coil
conformation in BPs and especially PBPs when compared
to ABPs (Fig. S2). In fact, propensities analysis reveal a
reduced preference of ABPs for coiled-coil conformation
(~0.25) in comparison the PBPs, which display a normal
trend for this secondary structure element (propensity ~1)
(Fig. 2). Although the intrinsic rigidity of Pro induces
the disruption of regular secondary structures (111), the
increased coiled-coil organization in PBPs cannot be attrib-
uted to this effect because the abundance of Pro is clearly
diminished in such regions (Fig. 1). Hence, the increased
preference for coiled-coil conformation in PBPs depicts
the larger requirements for flexibility in the binding of the
polar CL heads, further supporting the flexibility trends
observed in the amino acid compositions (see above). In
line with this conclusion is also the complete absence of
strand secondary structure conformations in PBPs. In
contrast to the PBPs, the ABPs prefer helices, and there is
a clear trend even beyond the overall abundance of helices
in our gold standard data set. Strand is also an acceptable
structural element, although the percentage is no higher
than observed in all chains. In line with this observation,
FIGURE 2 Relative propensity of observed secondary structures in all
protein chains (blue), BPs (green), ABPs (dark yellow), OBPs (purple),
and PBPs (red). The p-values for the statistical significance of differences
between propensities of each amino acid in different BPs are shown in
the lower panel, using the same color legend described in Fig 1.
Cardiolipin Interactions with Proteins 1287coiled coil is strongly disfavored in ABPs. These observa-
tions also support the conclusions from amino acid prefer-
ences, that the acyl chains favor rigid structured elements
to anchor on.Supersecondary structure motifs in CL-binding
regions
Recent studies show that loops, defined as supersecondary
structural motifs formed by a coiled region flanked by two
correlative regular secondary motifs (112), to be useful fea-
tures in the prediction of protein-protein interactions (30).
A database of such supersecondary structural motifs has
been built (44). With the aim of identifying putative specific
structural footprints of CL-binding sites, we extended our
analysis of CL-binding regions to the loops in this database.
94 different types of loops were observed in regions of CL-
binding proteins, 23 of which were located in different types
of BPs (Tables S2 and S3). 20 of these 23 were represented
in ABPs and only 12 of them were in PBPs. Moreover,
three of the loop types are exclusive to PBPs, 11 are exclu-
sive to ABPs, and 9 loop types are shared among PBPs andABPs. The frequencies of these loops in the CL-binding
proteins are shown in Fig. 3 A, and cartoon images of
these loop structures are depicted in Fig. 3 B. Most frequent
are loops GH_2.19.1 and HH_1.4.16. Most loops were
observed more frequently in PBPs than in ABPs, with
the exception of HH_1.4.16. PBP-exclusive loops are:
1) HG.0.1.1 for which two instances found in PBPs
(1OKC_A residues 26–40 and 4N7L_M residues 82–91),
and 2) EH.2.25.1 and EH.4M.6.1, which represent the
same supersecondary structural motif and was observed
once in PBPs (1SQP_A residues 317–348). All these loops
represent hydrophobic residue-rich helices in their original
structures and contain positively charged residues near the
flexible region of the loop. Only the N-terminal b-strand
of the EH motif in 1SQP_A is not in close proximity to
the polar head of CL.
Of the nine loop types shared among PBPs and ABPs
(Fig. 3 A), GH.2.19.1 shows the most remarkable preference
for PBPs. Four instances of this loop are present in three of
the proteins included in our analysis, and all of them are also
present in both PBPs and ABPs. This fact suggests a
possible relationship between this supersecondary structure
and the CL-binding function. Due to the lesser number of
loops mapped in BPs than in proteins (23 and 94, respec-
tively), and in PBPs than in ABPs (12 and 20, respectively),
the relative frequency of this loop is progressively higher in
BPs, ABPs, and PBPs. Remarkably, all structures clustered
in this loop type contain a Gly residue in the second position
of its flexible region (44), thus making it an extremely
conserved residue. This Gly is preceded by a positively
charged residue (Arg or Lys) in CL-binding proteins. A sec-
ond positively charged residue is located near this position,
allowing for the stabilization of the double negatively
charged CL polar head. Fig. 4 illustrates these details in
the example of the ATP/ADP carrier protein (PDB ID
1OKC), which has two different CL-binding sites. Strik-
ingly, in both of the binding sites a GH.2.19.1 loop is pre-
sent, showing that this particular protein adopted the same
structural solution for binding two CL molecules. Thus,
the presence of a GH.2.19.1 loop with a positively charged
residue preceding a crucial flexibility conferring Gly in the
phosphate binding region and a helix providing an anchor
for acyl chain binding, may be considered a footprint for
CL binding.Validity of predicted CL-binding sites
Approximately one-third of the proteins (22 of 62, 21 after
removing sequence redundancy) in the gold standard data
set have known CL bound cocrystal structures, and a further
21 have structures without CL (Table 1). This represents a
potentially rich source of structural features for analysis
and prediction of CL-binding sites. CL-protein docking
predictions have been used successfully in the structural
analysis of CL interactions previously (9,113–116) andBiophysical Journal 109(6) 1282–1294
FIGURE 3 (A) Relative frequencies of observed
supersecondary motifs (loops) in all protein chains
(blue), BPs (green), ABPs (dark yellow), OBPs
(purple), and PBPs (red). (B) Cartoon images of
the loops present in PBPs. Different secondary
structure elements are shown in color (helices in
red, strands in yellow, and coiled-coil regions in
green). Each motif is identified in the first text
line below by the code of its corresponding loop
type(s). The PDB file from where each loop struc-
ture shown was obtained, protein chain and starting
residue of the supersecondary structure are pro-
vided in the second line below each cartoon.
1288 Planas-Iglesias et al.have been useful in shedding light on the mechanisms gov-
erning such interactions. We therefore docked TLCL, the
most abundant CL species in mitochondria, to all structures
after removing all bound ligands in them, and analyzed
the results (see Materials and Methods section). Of the
top-ranked poses predicted by Autodock Vina, binding sites
were manually clustered together and highlighted in
File S2. In most cases, we predicted more than one binding
site. However, checking for overlap with the known CL-
binding sites in the 21 cocrystal structures (Table 2) indi-
cated that the prediction of binding sites by docking is
very effective. For 18 of the 21 analyzed proteins, the pre-
dicted CL docking poses overlapped with the crystallo-
graphic CL molecule annotated in the proteins’ structure.
Fig. 5 illustrates this overlap for the ATP/ADP carrier pro-
tein in its monomeric and dimeric forms. Clashes (docking
poses where CL molecule overlap with known protein-
protein interaction interfaces, see Materials and Methods)
were observed in 10 of the 18 binding sites, but seven of
them had at least one overlapping docking pose that was
free of clashes. The other 8 of 18 were completely free of
clashes.
Only TLCL was docked in this study, although there were
five different crystallographic identities of CL speciesBiophysical Journal 109(6) 1282–1294(CDL, CN3, CN5, CDN, and CD4). The fact that docking
was still able to identify the known CL-binding site despite
the different CL species used in docking provides important
evidence that docking with AutoDock Vina (51) is a highly
reliable method for identification of general CL-binding
sites in proteins. All of the poses obtained in the docking
are available in the Supporting Material as PyMol (39)
sessions (File S3), not only for the CL-cocrystal structures
but also structures lacking CL. This provides a rich source
of predictions that experimentalists can use to verify CL-
binding sites.Comparison of studied trends in crystallographic
CL-protein complexes to docking and negative
data sets
Taking advantage of all docked poses, we defined four new
sets of CL-binding protein costructures. The first one con-
tains all docking results in Table 2. The second and third
ones respectively contain the particular docking poses over-
lapping (positive docking control) and nonoverlapping
(negative control) with the crystallographic structure as
defined in Table 2 and Supporting Material File S2. The
fourth data set contains the results of docking TLCL to 30
FIGURE 4 Loops of ADP/ATP translocase 1
(PDB 1OKC chain A) interacting with two cardio-
lipin molecules. (A) One CL molecule (left) inter-
acts with loop GH_2.19.1 (1OKC_A_66; residues
66–99; colored in yellow).The second CLmolecule
(right) interacts with a different instance of loop
GH_2.19.1 (1OKC_A_266; residues 266–291;
colored in cyan), showing that both binding sites
adopt similar structural conformation. The second
molecule also interacts with loop HH_1.1.2
(1OKC_A_4; residues 4–37; colored in light or-
ange) and loop HG_0.1.1 (1OKC_A_26; residues
26–40; colored in pale yellow). Overlapping region
between HH_1.1.2 and HG_0.1.1 (residues 26–37)
is shown in brown). Positively charged amino acids
Arg and Lys in loop GH_2.19.1 are shown in blue,
and the conserved Gly in the loop motif is colored
in purple. (B) Enlarged images of areas circled in
(A) showing interaction between positively
charged residues and the phosphate groups of CL
in the two different binding sites, where CL bind-
ing is accomplished by different geometries. The
geometry of binding is described by measured dis-
tances between two proximal oxygen atoms in the
different CL phosphate groups to carbon beta and
distal nitrogen in relevant Arg (4.6 A˚ and 7.7 A˚,
respectively, left) or Lys (4.9 A˚ and 13.4 A˚, respec-
tively, right).
Cardiolipin Interactions with Proteins 1289nonredundant proteins for which no cocrystal was available.
Results of this comparison are provided in Figs. S3–S10
(amino acid and secondary structure elements propensity
values), and in File S4 (statistical significance for differ-
ences between trends in crystallographic complexes and
trends in the different docking data sets defined previously)
in the Supporting Material. Remarkably, docking results by
Autodock Vina of overlapping binding sites (docking posi-
tives) reproduce the electrostatic and hydrophobic features
described for crystallographic complexes, but not the flexi-
bility trends. For instance, docking positives as well as the
overall docking results show an enrichment of positively
charged residues in PBPs and OBPs, whereas in ABPs hy-
drophobic residues are predominant. If secondary structural
elements are considered, the ABPs preference for strand
conformation (compared to PBPs and OBPs) is then
confirmed. However, not even the controlled positives
from docking experiments are able to reproduce the unique
trend for Gly in PBPs or the preference for coiled-coil
conformation in PBPs and OBPs seen in the experimentally
observed crystal structure binding sites.DISCUSSION
In this work we made three contributions to the field of CL
binding to proteins. 1) We collected a gold standard data set
of all known CL binding proteins. This is the only system-
atic and to the best of our knowledge comprehensive listavailable to date. 2) Our BP analysis of the compiled set
of cocrystal structures not only confirmed for some CL
binding proteins the experimentally validated expectation
that hydrophobicity and charge play a role in binding, but
we also revealed a new, to our knowledge, and unexpected
feature important for binding: flexibility. Thus, a typical
binding patch is composed of positively charged or nonpolar
residues in PBPs and ABPs, respectively, with a remarkable
overrepresentation of Arg and Lys in PBPs and of Leu, Ile,
and Val in ABPs. In contrast, negatively charged residues
(Asp and Glu) are either underrepresented or disallowed
in PBPs. Furthermore, the region binding the polar head-
groups of the CL molecule shows a differential trend toward
increased flexibility, with a higher content of Gly and
coiled-coil secondary structure, and a lower content of
Pro. The only and remarkable case in which crystallo-
graphic data did not comply with these trends was that of
the hydrophobic residue Tyr, overrepresented in PBPs. Tyr
is a widely used residue in signaling due to its ability of be-
ing phosphorylated. Such phosphorylation may prevent CL
binding and could therefore be disfavored here. In addition,
Tyr usually participates in hydrogen bonding and it may
have other roles besides binding. For example, it may partic-
ipate in structural arrangements essential for catalytic func-
tions, similar to Tyr-67 in cytochrome c (117). Finally, in the
investigation of loop supersecondary structural motifs (44)
in BPs, loop GH.2.19.1., characteristic for the mitochondrial
ATP/ADP carrier, appeared particularly prominently. It isBiophysical Journal 109(6) 1282–1294
TABLE 2 Overlap analysis for PDBs with CL costructure(s)
UniProt PDB C. CL ID O. Cl. #DP #OP #CP #NCP #BS #OS #NCS
Homo-log
Struct-ure BE (kcal/mol) RMSD
P0AEK7 1KQF C CDL N NA 50 NA NA NA 5 NA NA NA NA NA
P0AAJ3 1KQG B CDL Y Y 9 9 8 1 1 1 1 NA 4.3 10.9
P02722 1OKC A CDL Y N 9 3 0 3 4 2 2 NA 4.0 11.6
P31800 1SQP A CDL N NA 50 NA NA NA 5 NA NA NA NA NA
P13271 1SQP G CDL Y N 9 1 0 1 3 1 1 NA 3.0 14.3
P00157 2A06 C CDL Y Y 50 5 2 3 5 1 1 2A06_P 5.5 13.3
P00125 2A06 D CDL Y Y 9 4 4 0 3 1 0 NA 3.5 12.8
P69054 2ACZ C CDN Y N 50 1 0 1 8 1 1 NA 5.2 11.8
P00163 3CX5 C CN5 Y Y 50 4 1 3 8 1 1 NA 6.8 17.5
P07143 3CX5 D CN3 Y Y 9 9 9 0 1 1 0 NA 4.5 15.9
P11609 3MA7 A CD4 Y N 9 7 0 7 2 1 1 NA 7.0 12.6
P18946 3TGU C CDL Y Y 50 10 1 9 8 1 1 3TGU_P 4.8 12.7
D0VX32 3TGU G CDL Y Y 50 5 4 1 5 1 1 NA 2.9 14.7
D0VX26 3TGU Q CDL Y Y 50 1 1 0 10 1 0 NA 5.0 12.0
P00415 3WG7 C CDL Y Y 50 4 1 3 6 1 1 NA 5.8 12.5
P07471 3WG7 G CDL N NA 50 NA NA NA 6 NA NA NA NA NA
Q9NRK6 3ZDQ A CDL Y N 9 3 0 3 2 1 1 NA 5.8 13.5
Q8TMG0 4A2N B CDL Y N 9 2 0 2 3 1 1 NA 4.6 13.4
P18239 4C9G A CDL Y N 50 3 0 3 8 1 1 NA 3.5 12.4
P18238 4C9J A CDL Y N 50 2 0 2 8 2 2 NA 3.4 14.5
P0C0Y9 4LWY M CDL Y Y 50 4 1 3 8 1 1 NA 5.8 13.6
The column UniProt shows the UniProt ID of the protein. PDB indicates the PDB structure ID. C. lists the chain of the PDB structure, which corresponds to
the UniProt ID. CL ID indicates the structure ID of the CL molecule that binds with the protein. O. shows whether the crystallographic CL molecule overlaps
with any of the docked CLs or not (Y and N, respectively); Cl. indicates whether any clash has occurred between the overlapping docking poses and other
chains of the PDB structure or not (Y and N, respectively); #DP gives the number of docking poses of the docked CL; #OP indicates the number of docking
poses of the docked CL overlapping with the CL crystallographic costructure; #CP shows the number of overlapping modes that clash with other chains of the
PDB structure; #NCP Number of overlapping modes which do not clash with any chain of the PDB structure; #BS shows the number of different manually
clustered binding sites of the docked CL; #OS indicates the number of binding sites including at least one pose overlapping with the CL crystallographic
costructure; #NCS shows the number of binding sites including at least one pose which do not clash with any chain of the PDB structure; Homolog structure
indicates an alternate structure file for the same protein (UniProt ID) in which an overlap between crystallographic CL and any docked one was observed in
cases where such overlap did not occur for the PDB and chain shown in columns 2 and 3. Crystal structures referred to in columns 2 and 3 were the ones
included in the nonredundant cocrystals subset described in main text. BE kcal/mol shows the lowest binding energy of the docked CL’s overlapping docking
pose. RMSD shows the root mean-square deviation between the lowest energy overlapping docked pose and the crystallographic pose of CL. NA here refers
to no overlap observed. Proteins in which no overlap between the crystallographic CL molecule and any docked one was observed show NA in Cl., #DP, #OP,
#CP, #NCP, #BS, #OS, #NCS, and BE kcal/mol columns.
1290 Planas-Iglesias et al.tempting to speculate that this loop containing a positively
charged residue preceding the crucial flexibility conferring
Gly in the PBP region, and a helix providing an anchor
for acyl chain binding, may be considered a footprint for
CL binding. 3) We carried out an exhaustive docking of
TLCL to all known structures of proteins experimentally
shown to interact with CL. This not only demonstrates
the validity of the docking approach, but also provided
new, to our knowledge, insights for designing further
experiments.
CL binding has initially been thought of as being domi-
nated by electrostatic forces (17,19,118), and our analysis
supports this notion. However, numerous studies have pro-
posed additional hydrophobic forces to contribute to binding
(19,21,66), a hypothesis also supported by our findings. A
popular model combining these two features is a two-step
process where electrostatic attraction initiates the interac-
tion of CL with protein, and hydrophobic contacts further
consolidate the binding to be of high affinity (20,66).
Recently, the role of electrostatic attraction has been chal-
lenged (86) because the crystal structures of the yeast mito-Biophysical Journal 109(6) 1282–1294chondrial ATP/ADP carrier (PDBs 4C9G, 4C9J) show that
the lateral chains of the positively charged residues preced-
ing the central conserved Gly are oriented in a plane perpen-
dicular to that defined by the phosphate groups in the CL
molecule, and pointing in the direction opposite to the phos-
phates. This led to the speculation that instead of direct
electrostatic interaction, CL interacts with the positively
charged end of the helix dipoles, which correspond to the
C-terminal secondary structure in loops GH.2.19.1 shown
in Fig. 4. Further insight can be gained from analysis of
the cattle mitochondrial ATP/ADP carrier (PDB 1OKC)
(55), which contains two different CL-BPs. In one of them
(Fig. 4, right), the lateral chain of the preceding Lys is ori-
ented analogous to the yeast mitochondrial ATP/ADP car-
rier, whereas the other binding site shows the lateral chain
of the Arg preceding Gly to be parallel to the plane defined
by the phosphate groups in the CL molecule (Fig. 4, left).
Our finding that flexibility appears to be an important
feature for binding of the phosphate groups, would suggest
that a wide spectrum of geometries of amino acid side
chains can be involved in CL binding to the same
FIGURE 5 Overlap of docked CL molecule with CL costructures of
1OKC and 4C9J. The docked CL is colored in cyan and the CL costructures
are colored in green. (A) Overlap with CDL 800 molecule of 1OKC; (B)
Overlap with CDL 801 molecule of 1OKC; (C) Overlap with CDL 802
molecule of 4C9J chain A (red).
Cardiolipin Interactions with Proteins 1291supersecondary motif. The high flexibility in these areas
would make it likely that the Lys side chains are not fixed
in space (either parallel or perpendicular) but are likely to
be dynamic and able to adopt multiple conformations.
This view is compatible with both models, direct electro-
static interactions of the phosphate groups with positively
charged amino acids or with the electric dipole created by
the helix. It is remarkable that loop GH.2.19.1, which we
propose here as a footprint of CL binding, is compatible
with all features, the previously proposed positive charge
and/or the electric helix dipole and the hydrophobic anchor.
In addition, we propose a direct role of flexibility in facili-
tating binding.
An important issue to address in the future is the role of
multiple chains in binding CL. The majority of CL cocrystal
structures contain multiple chains (14 of 18 pdb files) and
even though the HETATM field in the pdb code identifies
each CL molecule with a specific chain, there are contribu-
tions of neighboring chains to the binding pockets. This can
yield further insight into binding but can also help improve
the docking. Docking of the large protein complexes be-
comes highly challenging and multiple grid boxes are
required to cover the docking space. For illustration pur-
poses, we selected three pdb files containing multiple chains(File S6) and compared docking of the single chains with
docking of all chains (File S7). The comparison indicates
that highly complementary information can be obtained
by the two approaches, requiring further in-depth investiga-
tion for the contribution of interfaces to CL-binding pockets
in the future.
Although we have observed clear trends in BP properties
in CL-binding proteins, we have not yet explored specificity.
For example, other anionic phospholipids or even other
doubly negatively charged small molecules such as GDP
or ADP may show similar general structural and dynamics
features in their respective binding pockets. Hence, it is pre-
mature to regard the trends described here as specific to CL
binding. Conversely, we cannot ascertain if all CL binding
modes will be the same. In particular, there may be different
modes depending on the role of the CL interaction with pro-
teins. For example, in respirasomes, CL acts as a staple be-
tween the subunits. In contrast, in cytochrome c, CL appears
to remain membrane bound while interacting with the pro-
tein. In some proteins, CL binding has no demonstrated ef-
fect on function. Thus, different functional roles of CL
binding may be accomplished by yet unidentified modes
of binding and these may be specific to a given role.
At least for some types of CL-binding proteins—those
represented by the current data set—our studies open the
door for developing a generic algorithm for qualitatively pre-
dicting protein-CL interactions and for stratifying computed
binding sites from docking. By comparing a predicted bind-
ing site for the presence of specific amino acid types, second-
ary structures and supersecondary structures, it might be
possible to accurately select the actual binding pose of CLs
from several high-ranking docking poses. Furthermore, the
availability of a gold standard data set can be used in combi-
nation with suitable features to develop a general classifica-
tion model that can be applied at the system-wide level to
predict if a given protein may interact with CL or not.
Currently, work is underway to develop such a classifier.SUPPORTING MATERIAL
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